Investor Overview

Webcast ImageWebcast
Q1 2017 CryoLife, Inc. Earnings Conference Call (Replay)
04/27/17 at 8:00 a.m. ET
Webcast ImageWebcast
CryoLife, Inc. at Deutsche Bank Annual Health Care Conference (Live)
05/03/17 at 8:00 a.m. ET
Download Corporate Governance Documentation CryoLife Corporate Presentation
Corporate Profile

CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries.  It operates throughout the U.S. and internationally.  CryoLife manufactures and distributes BioGlue® Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels.  BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world.  CryoLife’s BioFoam® Surgical Matrix is CE marked in Europe for use as an adjunct to hemostasis in cardiovascular surgery and on abdominal parenchymal tissues (liver and spleen) when control of bleeding by ligature or conventional methods is ineffective or impractical.  CryoLife distributes PerClot®, a powdered hemostat, in Europe and other select international countries. . . More >>

CRY (Common Stock)
ExchangeNYSE (US Dollar)
Price$18.40
Change (%) Stock is Up 1.65 (0.00%)
Volume552,187
Data as of 04/27/17 4:02 p.m. ET
Refresh quote
Recent NewsMore >>
DateTitle
04/27/17CryoLife to Present at Deutsche Bank 42nd Annual Health Care Conference
04/27/17CryoLife Announces On-X Aortic Heart Valve PROACT Study Results to be Presented at American Association for Thoracic Surgery Centennial Meeting
04/26/17CryoLife Reports First Quarter 2017 Financial Results
Upcoming EventsMore >>
DateTitle
05/03/17 8:00 a.m. ET
CryoLife, Inc. at Deutsche Bank Annual Health Care Conference
Most Recent SEC FilingsMore >>
Filing DateFormDescriptionFiling GroupDownloads
04/27/1710-QQuarterly report which provides a continuing view of a company's financial positionQuarterly Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF Download XBRL Content
04/27/178-KReport of unscheduled material events or corporate eventCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
04/10/174Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
03/29/17DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Proxy Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
03/23/178-KReport of unscheduled material events or corporate eventCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
Data provided by Nasdaq. Minimum 15 minutes delayed.
Receive E-mail Alerts
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!